Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia by E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy

Get full text

Experience of successful autologous hematopoietic stem cell transplantation in patients with an unfavorable prognosis of systemic scleroderma by V. I. Mazurov, A. L. Maslyanskiy, K. E. Zotkina, S. S. Benevolenskaya, D. V. Motorin, A. Yu. Zaritskiy, E. A. Vasilenko, A. A. Vasilenko, A. M. Titova

Get full text

CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS by E. G. lisina, N. T. Siordiya, P. A. Butylin, A. A. Silyutina, N. M. Matyukhina, O. M. Senderova, E. S. Fokina, V. A. Ovsepyan, E. G. Lomaia, A. Yu. Zaritskiy

Get full text

Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia by A. A. Maschan, A. G. Rumyantsev, L. G. Kovaleva, B. V. Afanasiev, T. I. Pospelova, A. Yu. Zaritskiy, K. M. Abdulkadyrov, V. V. Ptushkin, N. V. Tsvetaeva, I. A. Lisukov, G. N. Salogub, A. K. Golenkov, N. V. Medvedeva, O. A. Rukavitsyn, V. L. Ivanova, I. V. Markova

Get full text